MENTHOL; METHYL SALICYLATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for menthol; methyl salicylate and what is the scope of patent protection?
Menthol; methyl salicylate
is the generic ingredient in one branded drug marketed by Hisamitsu Pharm Co and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Two suppliers are listed for this compound.
Summary for MENTHOL; METHYL SALICYLATE
| International Patents: | 20 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 6 |
| DailyMed Link: | MENTHOL; METHYL SALICYLATE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for MENTHOL; METHYL SALICYLATE
Generic Entry Date for MENTHOL; METHYL SALICYLATE*:
Constraining patent/regulatory exclusivity:
Dosage:
PATCH;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for MENTHOL; METHYL SALICYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Santiago de Compostela | Phase 4 |
| GlaxoSmithKline | Phase 4 |
| University Clinical Centre of Kosova | N/A |
US Patents and Regulatory Information for MENTHOL; METHYL SALICYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-001 | Feb 20, 2008 | OTC | Yes | Yes | 8,809,615 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-002 | Nov 5, 2012 | OTC | Yes | Yes | 8,809,615 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-002 | Nov 5, 2012 | OTC | Yes | Yes | 9,233,184 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for MENTHOL; METHYL SALICYLATE
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 2007279643 | Adhesive preparation | ⤷ Start Trial |
| Brazil | PI0712396 | preparação de adesivo | ⤷ Start Trial |
| Canada | 2652220 | PREPARATION ADHESIVE COMPORTANT DU SALICYLATE DE METHYLE POUR ABSORPTION PERCUTANEE (ADHESIVE PREPARATION COMPRISING METHYL SALICYLATE FOR PERCUTANEOUS ABSORPTION) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
